Clinical Trials are available to people across the U.S. through the NCI Clinical Oncology Research Program (NCORP), including 23 states with large rural populations SCOR serves three states with rural populations between 30% & 51% — North Carolina, South Carolina and Tennessee. SCOR also serves Florida, Georgia and Virginia, which have rural populations between 25% & 29%.
These statistics are important to understand because, as studies have shown, rural patients do not live as long as their urban counterparts. However, a study done by the Southwest Oncology Group (SWOG), the international cancer clinical trials network funded by the National Cancer Institute (NCI), indicates that this difference in survival is not due to patients – but to the care they receive.
NCORP aims to reduce these disparities by bringing the same treatments and standards of care that are the norm in large, urban and academic hospitals to smaller, rural community hospitals, health centers and medical practices. >>read more